Positive outcomes in largest liver transplant trial to date - Pharmacy Europe | Organ Donation & Transplant Matters Resources | Scoop.it

This report is on the positive outcomes achieved in the largest liver transplant trial of an immunosuppressive agent to date. New two-year results from the Phase III study in liver transplant recipients with the drug Everolimus in combination with other immunosuppressive agents have confirmed that there was comparable efficacy in the treatment arm to the control arm. Plus superior renal function was seen in the treatment arm during the study period.


As a result Everolimus will now become another immunosuppressive agent that may be used in the ongoing management of liver transplant recipients.